Cargando…
Lipogenic metabolism: a viable target for prostate cancer treatment?
Cancer cells often depend on altered metabolism compared with their normal counterparts.1234 As observed in 1924 by Otto Warburg, cancer cells show preferential glucose consumption by way of aerobic glycolysis while normal cells generally assume mitochondrial oxidative phosphorylation.4 Another meta...
Autores principales: | Liang, Mengmeng, Mulholland, David J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215688/ https://www.ncbi.nlm.nih.gov/pubmed/24969061 http://dx.doi.org/10.4103/1008-682X.132947 |
Ejemplares similares
-
To screen or not to screen: the prostate cancer dilemma
por: Stone, Nelson N, et al.
Publicado: (2015) -
Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment
por: Lv, Jialu, et al.
Publicado: (2020) -
Locally-advanced prostate cancer in the elderly: should we revisit our treatment paradigms?
por: Lughezzani, Giovanni, et al.
Publicado: (2015) -
ARASENS: making sense out of first-line metastatic hormone-sensitive prostate cancer treatment
por: Aragon-Ching, Jeanny B
Publicado: (2022) -
Prostate cancer screening: and yet it moves!
por: Kwiatkowski, Maciej, et al.
Publicado: (2015)